Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.

@article{Mir2011LossOA,
  title={Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.},
  author={Carmen Mir and Shahrokh F Shariat and Theodorus H. van der Kwast and Raheela Ashfaq and Yair Lotan and A Patrice Evans and Sean C. Skeldon and Sally Hanna and Rati Vajpeyi and Cynthia Kuk and Sultan Alkhateeb and J M S{\'a}nchez Morote and Bas Wilhelmus Gerardus van Rhijn and Peter J. Bostrom and Jorge Yao and Hiroshi Miyamoto and Michael A. S. Jewett and Neil E. Fleshner and Edward Messing and Alexandre R. Zlotta},
  journal={BJU international},
  year={2011},
  volume={108 1},
  pages={24-30}
}
OBJECTIVE • To investigate androgen receptor (AR) expression in a large series of patients with bladder cancer (BC) because data on a limited number of patients showed that loss of AR expression was associated with invasive BC. PATIENTS AND METHODS • A total of 472 patients with urothelial bladder carcinoma (UBC) from two institutional centres (Toronto and Dallas) were analysed. Tissue microarrays comprising both non-muscle-invasive UBC (n= 167) and muscle-invasive UBC (n= 305) were accrued… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 48 extracted citations

Similar Papers

Loading similar papers…